share_log

方舟生物医药将于2024年9月3日除权除息,12股合为1股

ARCA Biopharma To Carry Out 1-for-12 Reverse Stock Split On September 3rd, 2024

Futu News ·  Aug 30 07:40

August 29th (Eastern Time) - $ARCA biopharma (ABIO.US)$ is about to implement a 1-for-12 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from September 3rd, 2024.

$ARCA biopharma (ABIO.US)$ slipped 10.05% and closed at $1.8769918 on August 28th with a turnover of $940.64K. $ARCA biopharma (ABIO.US)$ now has a total market capitalization of $27.22 million.


What Is a Reverse Stock Split?

A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.

Note:

The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment